Docusign’s (DOCU) Market Outperform Rating Reiterated at Citizens Jmp

Citizens Jmp reissued their market outperform rating on shares of Docusign (NASDAQ:DOCUFree Report) in a research note published on Friday morning,Benzinga reports. They currently have a $86.00 price objective on the stock.

DOCU has been the topic of several other research reports. UBS Group set a $60.00 target price on shares of Docusign in a research report on Friday, June 5th. BTIG Research raised their price target on shares of Docusign from $60.00 to $75.00 and gave the company a “buy” rating in a research note on Wednesday, September 2nd. Needham & Company LLC reaffirmed a “hold” rating on shares of Docusign in a research note on Friday. Piper Sandler lifted their price objective on Docusign from $52.00 to $75.00 and gave the stock a “neutral” rating in a report on Friday. Finally, Morgan Stanley boosted their price objective on Docusign from $69.00 to $75.00 and gave the stock an “equal weight” rating in a research note on Friday. Three analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $67.33.

View Our Latest Report on Docusign

Docusign Price Performance

Shares of DOCU stock opened at $68.41 on Friday. Docusign has a 1-year low of $40.16 and a 1-year high of $86.65. The company has a market cap of $13.06 billion, a price-to-earnings ratio of 41.71, a PEG ratio of 2.43 and a beta of 0.90. The stock has a 50 day simple moving average of $55.70 and a 200-day simple moving average of $49.90.

Docusign (NASDAQ:DOCUGet Free Report) last released its quarterly earnings results on Thursday, September 3rd. The company reported $1.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.09 by $0.07. The firm had revenue of $875.75 million for the quarter, compared to analysts’ expectations of $867.22 million. Docusign had a net margin of 9.82% and a return on equity of 18.29%. The firm’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.30 EPS. Analysts anticipate that Docusign will post 2.03 earnings per share for the current fiscal year.

Insider Buying and Selling at Docusign

In other news, insider James Shaughnessy sold 12,000 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total value of $546,480.00. Following the transaction, the insider directly owned 52,815 shares of the company’s stock, valued at approximately $2,405,195.10. This trade represents a 18.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director James Beer sold 450 shares of the business’s stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $64.02, for a total transaction of $28,809.00. Following the transaction, the director owned 14,586 shares in the company, valued at $933,795.72. The trade was a 2.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 90,602 shares of company stock valued at $4,323,749. 0.59% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in DOCU. BlackRock Inc. acquired a new stake in shares of Docusign in the second quarter valued at approximately $927,059,000. California State Teachers Retirement System lifted its position in Docusign by 4,016.6% during the second quarter. California State Teachers Retirement System now owns 9,960,652 shares of the company’s stock worth $442,452,000 after buying an additional 9,718,686 shares in the last quarter. Norges Bank acquired a new position in Docusign during the fourth quarter worth $186,795,000. Arrowstreet Capital Limited Partnership boosted its stake in Docusign by 76.1% during the first quarter. Arrowstreet Capital Limited Partnership now owns 5,285,128 shares of the company’s stock worth $250,568,000 after buying an additional 2,283,996 shares during the last quarter. Finally, Capital World Investors grew its holdings in Docusign by 38.1% in the 4th quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock valued at $397,801,000 after buying an additional 1,603,900 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Key Docusign News

Here are the key news stories impacting Docusign this week:

  • Positive Sentiment: Quarterly results exceeded expectations. DocuSign reported revenue of $875.7 million, up 9.4% year over year and ahead of the $867.2 million consensus estimate. Adjusted earnings of $1.16 per share also surpassed expectations of approximately $1.08-$1.09. DocuSign Announces Second Quarter Fiscal 2027 Financial Results
  • Positive Sentiment: Management raised its fiscal 2027 outlook. The company increased guidance for revenue, annual recurring revenue (ARR) and the percentage of ARR generated by its Intelligent Agreement Management (IAM) platform. Third-quarter revenue guidance of $886 million-$890 million was broadly in line with analyst expectations. DocuSign raises annual forecast as AI-powered contract tools gain traction
  • Positive Sentiment: AI and IAM adoption are becoming key growth drivers. New AI-powered contract tools are gaining traction, while stronger retention and IAM momentum suggest DocuSign is broadening its addressable market beyond electronic signatures. CFO Blake Grayson said strengthening partnerships supported the higher ARR forecast.
  • Positive Sentiment: DocuSign is opening its Model Context Protocol server to all AI agents globally on September 30. The initiative could make DocuSign’s agreement technology more accessible across agentic enterprise software ecosystems and support future platform usage. DocuSign Agreement Layer for the Agentic Enterprise Coming to Every Agent
  • Positive Sentiment: Several analysts raised their price targets following the earnings report, including UBS to $70, BTIG to $75 and Citizens JMP to $86. Morgan Stanley also reportedly increased its target, while technical traders noted a bullish “golden cross.”
  • Neutral Sentiment: Analyst opinion remains divided. Bank of America raised its target to $64 but retained an “underperform” rating; UBS maintained “neutral,” and Needham reiterated “hold.” This suggests some analysts view the recent rally as having already priced in much of the improvement.
  • Negative Sentiment: The stock reversed some early gains despite the earnings beat. With shares trading well above their 200-day average and at a relatively elevated earnings multiple, investors may be concerned that expectations for AI-driven growth are becoming demanding.

About Docusign

(Get Free Report)

Docusign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, Docusign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, Docusign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

Docusign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Read More

Analyst Recommendations for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.